Fewer Mutations in Tumor Mitochondria

Contrary to existing dogma, colon cancer cell mitochondria carry fewer mutations than mitochondria of normal body cells.

Written byHayley Dunning
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Mitochondria light up a cell.THE CELL

Mitochondrial DNA (mtDNA) in colon cancer cells undergoes less frequent mutation than healthy body cell mtDNA, according to a study published in PLoS Genetics this week (June 7). The finding flies in the face of the popular belief that tumor cell DNA is more highly mutated than the genetic code of normal cells, as has been established for nuclear DNA, and suggests a decoupling of nuclear and mitochondrial processes as colon cancer advances.

“The result impacts our understanding of the underlying mechanisms that take place during carcinogenesis,” said Lars Eide, a medical biochemistry professor at the Institute of Clinical Medicine in Oslo who works on mtDNA stability but was not involved in the study, by e-mail. “The increased fidelity of mtDNA during the carcinogenic process ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies